Clinical Trial Update: First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas [Phase 2, Phase 3]

View source ↗

Summary

This document describes the first clinical study using an Erbium-YAG laser to vaporize cutaneous neurofibromas, spanning Phase 2 and Phase 3; the current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Neurofibromas
• Neurofibromatosis Type

Snippet

Sponsor: Medical University of Vienna | Conditions: Cutaneous Neurofibromas | Phase 2, Phase 3 | Status: UNKNOWN